# Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

> **NCT06780202** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 180 (estimated)

## Conditions studied

- Foot Injuries and Disorders
- Ankle Injuries and Disorders
- Achilles Tendon Injury

## Interventions

- **DRUG:** medrol dosepak
- **DRUG:** HYDROcodone Oral Tablet

## Key facts

- **NCT ID:** NCT06780202
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-27
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780202, "Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06780202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*